According to the Complaint, Forescout Technologies, Inc. provides “security at first sight” by delivering software that enables device visibility and control that enables enterprises and government agencies to gain improved situational awareness of their environment (devices on their networks) and orchestrate actions to reduce cyber and operational risk.

According to the Complaint, Hebron Technology Co., Ltd. conducts equipment and engineering service operations focusing on the research, development and manufacture of fluid equipment including valves, pipe fittings and others. Since July 2019, the Company has also provided financial advisory service operations.

According to the Complaint, KLX Energy Services Holdings, Inc. is a leading U.S. onshore provider of mission critical oilfield services focused on completion, intervention, and production activities for the most technically demanding wells.

According to the Complaint, Wells Fargo is a diversified financial services company that provides banking, investment, mortgage, and consumer and commercial finance products and services to individuals, businesses, and institutions in the U.S. and internationally.

According to the Complaint, Qiagen N.V. is the leading global provider of Sample to Insight solutions that enable customers to gain molecular insights from samples. The Company's sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

According to the Complaint, Portola Pharmaceuticals, Inc. is a global, commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions.

According to the Complaint, Carnival Corporation bills itself as the world’s largest leisure travel company and the largest cruise company, carrying nearly 45 percent of global cruise guests. The Company has operations in North America, Australia, Europe and Asia, operating a portfolio of global, regional and national cruise brands that sell tailored cruise products, services and vacation experiences on 104 cruise ships to destinations around the world.

According to the Complaint, Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, and metabolic and infectious diseases. On May 8, 2020, Sorrento announced a collaboration with Mount Sinai Health System for the purpose of “generat[ing] antibody products that would act as a ‘protective shield’ against SARSCoV-2 coronavirus infection, potentially blocking and neutralizing the activity of the virus in naïve at-risk populations as well as recently infected individuals.”

According to the Complaint, Colony Capital, Inc. is a leading global investment management firm with assets under management of $55 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, and traded and non-traded real estate investment trusts.

According to the Complaint, Hamilton Beach Brands Holding Co., together with its subsidiaries, designs, markets, and distributes small electric household and specialty housewares appliances. The Company sells its products through a network of mass merchandisers, e-commerce retailers, national department stores, variety and drug store chains, specialty home retailers, distributors, and other retail outlets.

According to the Complaint, Taubman Centers, Inc. is an S&P MidCap 400 Real Estate Investment Trust engaged in the ownership, management, and/or leasing of twenty-six regional, super-regional, and outlet shopping centers in the United States and Asia.

According to the Complaint, CytomX Therapeutics operates as an oncology-focused biopharmaceutical company in the U.S. The Company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer. CytomX’s lead product candidates in the clinical stage include, among others, CX-072, a Probody therapeutic targeting programmed cell death ligand 1 immuno-oncology target; and CX-2009, a Probody drug conjugate (PDC) against CD166 novel drug target.

According to the Complaint, Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics.

According to the Complaint, Ryder is a global provider of transportation and supply chain management products, including leasing trucks to end users.

According to the Complaint, Elanco Animal Health Incorporated is an animal health company that develops, manufactures, and markets products for companion and food animals.

According to the Complaint, Conn’s Inc. is a specialty retailer that sells branded durable consumer goods. Conn’s has two reportable segments: (i) retail, which includes product categories such as furniture, home appliance, consumer electronics, and home office; and (ii) credit, which includes the Company’s in-house consumer credit programs.

According to the Complaint, Willis Towers Watson Public Limited Company is a leading global advisory, brokering, and solutions company that designs and delivers solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals.

According to the Complaint, Grand Canyon Education, Inc. is an education services company. The claims alleged in this case arise from Defendants' misrepresentations and omissions regarding Grand Canyon's spin-off of its education assets to become purported non-profit, independent entity Grand Canyon University ("GCU").

According to the Complaint, Comtech Telecommunications Corp. provides communications solutions for both commercial and government customers worldwide.

According to the Complaint, Hallmark Financial Services, Inc. is a diversified property/casualty insurance group.